Search - tctmd.com

Displaying 241 - 260 of 332

Sort: Relevancy | Date

News Daily News

Short Safety Course for Operators Lowers Radiation Dose for Patients

Yael L. Maxwell

March 21, 2014

News Daily News

ZES Continue to Match EES in All Comers at 4 Years

March 13, 2014

News Daily News

4年数据显示ZES在所有方面均可媲美EES

March 13, 2014

News Daily News

DEFER-STEMI Published: Delayed Stenting Improves Outcomes in Higher-Risk STEMI Patients

March 05, 2014

News Daily News

DUTCH PEERS Published: Third-Generation Zotarolimus, Everolimus Stents Equivalent

February 12, 2014

News Daily News

DUTCH PEERS Publicado: Los Stents liberadores de Zotarolimus y Everolimus de 3ª Generación son Equivalentes

February 12, 2014

Presentation

Third-Gen ZES and EES in All-Comers Patients Requiring PCI: DUTCH PEERS Noninferiority Trial

Presenter: Clemens von Birgelen

February 09, 2014

News Daily News

Better Outcomes Seen with Prasugrel vs High-Dose Clopidogrel in Select ACS Patients

Yael L. Maxwell

January 30, 2014

News Daily News

IVUS Guidance Reduces Stent Thrombosis, MACE Compared to Angiography

December 08, 2013

News Conference News TCT 2013

Clamping Intolerance Predicted by Low Clamping Pressure in Carotid Stenting

November 07, 2013

Presentation TCT 2013

DUTCH PEERS (TWENTE II): A Prospective, Randomized, "All-Comers" Trial of Third-Generation Zotarolimus-Eluting Stents vs. Everolimus-Eluting Coronary Stents

Presenter: Clemens von Birgelen

October 31, 2013

News Conference News TCT 2013

DUTCH PEERS: Third-Generation Stents Equivalent, Effective

October 31, 2013

News Industry News

Comparison of Two Third-Generation Drug-Eluting Stents Establishes Comparable Safety and Efficacy; Demonstrates Non-Inferiority of Newest Zotarolimus-Eluting Stent

October 31, 2013

News Conference News TCT 2013

SORT-OUT VI: Permanent Polymer ZES Noninferior to Biodegradable BES in All-Comers Study

October 30, 2013

Presentation TCT 2013

SORT-OUT VI: A Prospective, Randomized, All-Comers Trial of Biodegradable Polymer-Coated Biolimus-Eluting Stents vs. Biocompatible Polymer-Coated Zotarolimus-Eluting Coronary...

Presenter: Bent Raungaard

October 29, 2013

News Conference News TCT 2013

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

October 28, 2013

News Daily News

SYNTAX: Stent Thrombosis Has Greater Impact on Mortality Than Graft Occlusion

Leah Lawrence

October 25, 2013

News Industry News

Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013

October 17, 2013

News Daily News

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

October 15, 2013

News Daily News

EXECUTIVE：依维莫司在治疗非复杂多支病变中效果良好

October 15, 2013

Advertisement

Short Safety Course for Operators Lowers Radiation Dose for Patients

ZES Continue to Match EES in All Comers at 4 Years

4年数据显示ZES在所有方面均可媲美EES

DEFER-STEMI Published: Delayed Stenting Improves Outcomes in Higher-Risk STEMI Patients

DUTCH PEERS Published: Third-Generation Zotarolimus, Everolimus Stents Equivalent

DUTCH PEERS Publicado: Los Stents liberadores de Zotarolimus y Everolimus de 3ª Generación son Equivalentes

Third-Gen ZES and EES in All-Comers Patients Requiring PCI: DUTCH PEERS Noninferiority Trial

Better Outcomes Seen with Prasugrel vs High-Dose Clopidogrel in Select ACS Patients

IVUS Guidance Reduces Stent Thrombosis, MACE Compared to Angiography

Clamping Intolerance Predicted by Low Clamping Pressure in Carotid Stenting

DUTCH PEERS (TWENTE II): A Prospective, Randomized, "All-Comers" Trial of Third-Generation Zotarolimus-Eluting Stents vs. Everolimus-Eluting Coronary Stents

DUTCH PEERS: Third-Generation Stents Equivalent, Effective

Comparison of Two Third-Generation Drug-Eluting Stents Establishes Comparable Safety and Efficacy; Demonstrates Non-Inferiority of Newest Zotarolimus-Eluting Stent

SORT-OUT VI: Permanent Polymer ZES Noninferior to Biodegradable BES in All-Comers Study

SORT-OUT VI: A Prospective, Randomized, All-Comers Trial of Biodegradable Polymer-Coated Biolimus-Eluting Stents vs. Biocompatible Polymer-Coated Zotarolimus-Eluting Coronary...

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

SYNTAX: Stent Thrombosis Has Greater Impact on Mortality Than Graft Occlusion

Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

EXECUTIVE：依维莫司在治疗非复杂多支病变中效果良好

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content